Hide Board Information

Show Board Information

Millicom International Cellular S.A. TIGO

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/25/2023 4:26:26 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Millicom International Cellular S.A. (OTCMRKTS: TIGO) Stock Message Board

1. TIGO Company Profile

    

2. TIGO Time & Sales

    

3. TIGO Recent News

    

4. TIGO Filings

    

5. TIGO Financials

    

6. TIGO Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	$TIGO 23% v2,2M c18.25 f170,890M H18.31 ML12.53	znewcar1	01/25/2023 4:26:26 PM
4	MIICF Financials 07/16/2014 20:04:33 Millicom	Emylers	07/16/2014 9:04:29 PM
3	Latest Millicom International Cellular S.A.	Stock_Tracker	03/10/2014 2:00:44 PM
2	MIICF 105.57 Stock Charts $MIICF 1 Month Chart	chartguy89	03/08/2014 2:36:23 PM
1	MIICF Stock Charts Last: +0.97 Thursday, February	chartguy89	02/27/2014 11:30:43 PM

Recent Articles

• Transforming DeFi: The Rise of Intelligent AI Superagents
• Strategic Resources' AGM Delivers Positive Results for Shareholders
• TriNet Declares Quarterly Dividend to Enhance Shareholder Value
• FMC Corporation Welcomes Anthony DiSilvestro to Board of Directors
• MSA Safety to Lead Discussion on Advanced Safety Technology
• Iconic Minneapolis Wells Fargo Center Acquired by Top Investors
• Carnegie Learning Celebrates Third Recognition on GSV 150 List
• Repare Therapeutics Shares Promising Data on New Cancer Treatment
• LeddarTech Secures Key Royalty Payment from Texas Instruments
• E2open to Release Third Quarter Financial Results Soon
• EPR Properties Announces Monthly and Quarterly Dividend Payouts
• Arby’s Unveils Thighsman Award with Joe Theismann's Support
• JPMorganChase Welcomes Michele G. Buck to Leadership Team
• Transforming Skincare: Ourself Unveils Revolutionary Delivery Tech
• Transforming IT Roles: Navigating Cybersecurity and Cloud Challenges
• ThriveDX Expands University Partnerships in Cybersecurity Training
• John Hancock's Fund Transition to Diversified Income Strategy
• Leadership Shift at Darling Ingredients Inc. Marks New Era
• John Hancock Funds Enhance Shareholder Value through Repurchase Plans
• CoolIT Systems Enhances Production to Meet AI Demand
• Commercial Metals Company Embraces Sustainability for 2024
• Canaan Inc. Strengthens Market Position with New Partnership
• Vir Biotechnology's New Breakthroughs in Hepatitis Delta Therapy
• Kuehn Law Advocates for Empire Petroleum Corp Investors
• Top Early Childhood Curriculum Innovator Earns GSV 150 Distinction
• Aurora Innovation Launches Cutting-Edge Lidar Facility
• Corcept Reveals Groundbreaking CATALYST Trial Results for Diabetes
• Lawrence (Liren) Chen Joins Arrow Electronics Board of Directors
• WD-40 Company Strengthens Leadership with New Chairman Appointment
• Moshe Gavrielov Joins Cadence's Board of Directors
• Boosting EV Infrastructure: EVgo Secures $1.25 Billion Loan
• Good Times Restaurants Sees Growth Amid Operational Change
• Scorpio Tankers Secures $500 Million Credit Facility to Boost Growth
• RH's Third Quarter Performance: Insights and Financial Overview
• Wabash Unveils Innovative Features for 2026 DuraPlate Dry Van
• McGrath RentCorp Announces New Quarterly Dividend Plans
• Costco Wholesale Achieves Record Sales and Income Growth
• Barings Corporate Investors Declares Dividends for Shareholders
• Tavia Acquisition Corp. Completes Successful IPO with Full Over-Allotment
• Arcosa, Inc. Announces Dividend and Share Buyback Plan Update
• Cherry Hill Mortgage Investment Corporation Announces Q4 2024 Dividends
• DHT Holdings Announces Strategic Sale of DHT Scandinavia
• Redwood Trust Boosts Dividend by 5.9% to Enhance Shareholder Value
• Portage Biotech's Nasdaq Listing Compliance Journey Ahead
• Equity Residential's Quarterly Dividends Announced for Shareholders
• Inventiva Announces Voting Outcomes from Recent Shareholder Meeting
• AG Growth International Declares Fourth Quarter Dividend for 2024
• Zoetis Announces Significant Dividend Increase for 2025
• Barings Participation Investors Declares Special Dividend Boost
• Editas Medicine's New Direction: Focusing on In Vivo Gene Editing